Telimit H 40mg/12.5mg Tablet

Short Description

Telimit H 40mg/12.5mg Tablet is a combination of two medicines that help control high blood pressure. It is used when one medicine alone is not effective in controlling blood pressure, reducing the risk of heart attack or stroke.

Dosage Form

Tablet

Introduction

Telimit H 40mg/12.5mg Tablet is a combination of two medicines that help control high blood pressure. It is used when one medicine alone is not effective in controlling blood pressure, reducing the risk of heart attack or stroke. The medicine is generally used to treat hypertension, which is a condition where the blood pressure in the arteries is elevated.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Telimit H 40mg/12.5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Side Effects

No common side effects listed.

Alcohol Warning

It is not known whether it is safe to consume alcohol with Telimit H 40mg/12.5mg Tablet. Please consult your doctor.

Breastfeeding Warning

Telimit H 40mg/12.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Pregnancy Warning

Telimit H 40mg/12.5mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Telimit H 40mg/12.5mg Tablet is a combination of two medicines that work together to control high blood pressure.

It can be taken with or without food. It may cause dehydration, so drink plenty of fluids and inform your doctor if you develop extreme thirst, very dry mouth, or muscle weakness. It may cause dizziness, so get up slowly when rising from a sitting or lying position. Use of Telimit H 40mg/12.5mg Tablet during pregnancy or breastfeeding is unsafe.